July 18, 2025 - 02:59

Researchers at The Hong Kong University of Science and Technology (HKUST) have unveiled a groundbreaking artificial intelligence technology that significantly reduces radiation exposure during medical imaging procedures. This innovative system reconstructs highly accurate 3D models of bones and organs using only a minimal number of X-ray images, cutting radiation exposure by an astonishing 99%.
The development addresses long-standing concerns regarding the health risks associated with traditional X-ray imaging, which often requires multiple exposures to obtain clear images. By leveraging advanced AI algorithms, the technology can effectively interpret limited data, generating detailed anatomical models that enhance diagnostic accuracy while prioritizing patient safety.
This advancement not only promises to improve the quality of medical imaging but also paves the way for safer healthcare practices. Experts believe that this technology could transform the landscape of medical diagnostics, making it more accessible and less harmful for patients. The implications for future medical imaging techniques are profound, heralding a new era in patient care and safety.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...